Literature DB >> 11740155

Imbalance in the synthesis of collagen type I and collagen type III in smooth muscle cells derived from human varicose veins.

P Sansilvestri-Morel1, A Rupin, C Badier-Commander, P Kern, J N Fabiani, T J Verbeuren, P M Vanhoutte.   

Abstract

Varicose veins have a thickening wall. Their smooth muscle cells are disorganized as regards proliferation and production of extracellular matrix protein. An imbalance between the synthesis of collagen type I protein (collagen I) and collagen type III protein (collagen III) could explain the lack of elasticity of varicose veins. Therefore, collagen synthesis was compared in the media and in cultured smooth muscle cells derived from human control and varicose saphenous veins. An increase in total collagen synthesis was observed in the media and in smooth muscle cells derived from varicose veins. This augmentation was due to an overproduction of collagen I in cultured cells from varicose veins consistent with an increase in the release of collagen I metabolites in the media. A concomitant decrease in collagen III was observed in cultures of smooth muscle cells from varicose veins. The increase in the synthesis of collagen I in cells from varicose veins was correlated with an overexpression of the gene since mRNAs for collagen I were augmented without change in mRNA-half-life. This augmentation in the synthesis of collagen I was reduced by the addition of exogenous collagen III in cultures from varicose veins. These findings suggest a dysregulation of the synthesis of collagen I and III in smooth muscle cells derived from varicose veins. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11740155     DOI: 10.1159/000051092

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  25 in total

1.  Effects of cobalt chloride on phenotypes of normal human saphenous vein smooth muscle cells.

Authors:  Jing Li; Huai-Ming Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Flow cytometric characterization of the saphenous veins endothelial cells in patients with chronic venous disease and in patients undergoing bypass surgery: an exploratory study.

Authors:  Cláudia Torres; Rui Machado; Margarida Lima
Journal:  Heart Vessels       Date:  2019-06-21       Impact factor: 2.037

3.  Venous pathophysiology.

Authors:  Chieh-Min Fan
Journal:  Semin Intervent Radiol       Date:  2005-09       Impact factor: 1.513

4.  Does extracellular matrix of the varicose vein wall change according to clinical stage?

Authors:  Mehmet Ali Demirkıran; Cüneyt Köksoy; Aylin Okçu Heper; Uğur Bengisun
Journal:  Ulus Cerrahi Derg       Date:  2014-12-01

Review 5.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 6.  Vascular wall extracellular matrix proteins and vascular diseases.

Authors:  Junyan Xu; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2014-07-18

7.  Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research.

Authors:  Ferdinando Mannello; Joseph D Raffetto
Journal:  Am J Transl Res       Date:  2010-11-23       Impact factor: 4.060

Review 8.  Molecular Aspects of Wound Healing and the Rise of Venous Leg Ulceration: Omics Approaches to Enhance Knowledge and Aid Diagnostic Discovery.

Authors:  Daniel A Broszczak; Elizabeth R Sydes; Daniel Wallace; Tony J Parker
Journal:  Clin Biochem Rev       Date:  2017-02

Review 9.  Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.

Authors:  Yunfei Chen; Wei Peng; Joseph D Raffetto; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-21       Impact factor: 3.622

10.  Sex, collagen expression, and anterior cruciate ligament strength in rats.

Authors:  William A Romani; Patricia Langenberg; Stephen M Belkoff
Journal:  J Athl Train       Date:  2010 Jan-Feb       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.